REUMOFAN PLUS Tablets, 30 Tablet Bottles, OTC. Previene el cancer en los huesos, Nueva presentacion el original.
Published May 21, 2014 · Recall initiated: March 13, 2014
Summary
FDA records drug Class I recall D-1322-2014, published May 21, 2014 and initiated March 13, 2014. Recalling firm: Pain Free By Nature; Status: Terminated; Reported quantity: 7,123 bottles; Lot: All lots. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without an Approved NDA/ANDA; Product contains undeclared diclofenac and methocarbamol.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pain Free By Nature
- Distributor
- Nationwide including Puerto Rico
- Lot
- All lots
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASterile Water for Injection, 5 mL ampoules, packaged in 50-count ampoules per box, Manufactured andMay 21, 2014
- FDASmart Tab First Aid ezRefill System Ibuprofen dispenser boxes (Item Number FAE 7014), 20 count boxes, FirstMay 21, 2014
- FDAVitamin C (ascorbic acid) Injection, USP, 500 mg per 2 mL, 50 x 2 mL ampoules per box, Manufactured by: TPMay 21, 2014
- FDAMETHYLDOPA Tablets USP, 500 mg, 100 count bottle, Rx only, Manufactured In INDIA By: EMCURE PHARMACEUTICALSMay 21, 2014
- FDARelumins Advanced Glutathione (lyophilized glutathione/vitamin C) injectable solution, 1500 mg/500 mg,May 21, 2014
- FDAFernandez True Chile Flavor, Medium Hot Chile Molido Puro, 4 oz.May 21, 2014
Questions about this recall
Was REUMOFAN PLUS Tablets, 30 Tablet Bottles, OTC. Previene el cancer en los huesos, Nueva presentacion el original. recalled?
Yes. FDA published recall D-1322-2014 on May 21, 2014. Reported hazard: Marketed Without an Approved NDA/ANDA; Product contains undeclared diclofenac and methocarbamol.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release